HEADER TRANSFERASE/TRANSFERASE INHIBITOR 03-JUN-15 5BUI
TITLE ERK2 COMPLEXED WITH 2-PYRIDIYL TETRAHYDROAZAINDAZOLE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED KINASE 2,ERK-2,
COMPND 5 MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED PROTEIN KINASE 2,
COMPND 6 MAPK 2;
COMPND 7 EC: 2.7.11.24;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PDEST1
KEYWDS ERK2, MITOGEN-ACTIVATED PROTEIN KINASE 1, ATP-INHIBITOR, TRANSFERASE-
KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR C.R.BELLAMACINA,W.SHU,D.E.BUSSIERE,J.T.BAGDANOFF
REVDAT 3 27-SEP-23 5BUI 1 REMARK LINK
REVDAT 2 12-AUG-15 5BUI 1 SOURCE JRNL
REVDAT 1 15-JUL-15 5BUI 0
JRNL AUTH J.T.BAGDANOFF,R.JAIN,W.HAN,D.POON,P.S.LEE,C.BELLAMACINA,
JRNL AUTH 2 M.LINDVALL
JRNL TITL LIGAND EFFICIENT TETRAHYDRO-PYRAZOLOPYRIDINES AS INHIBITORS
JRNL TITL 2 OF ERK2 KINASE.
JRNL REF BIOORG.MED.CHEM.LETT. V. 25 3626 2015
JRNL REFN ESSN 1464-3405
JRNL PMID 26144345
JRNL DOI 10.1016/J.BMCL.2015.06.063
REMARK 2
REMARK 2 RESOLUTION. 2.12 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.2
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.70
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8
REMARK 3 NUMBER OF REFLECTIONS : 21324
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.172
REMARK 3 R VALUE (WORKING SET) : 0.169
REMARK 3 FREE R VALUE : 0.222
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140
REMARK 3 FREE R VALUE TEST SET COUNT : 1095
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.22
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.76
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL
REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2733
REMARK 3 BIN R VALUE (WORKING SET) : 0.1897
REMARK 3 BIN FREE R VALUE : 0.2588
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.63
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 154
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2743
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 23
REMARK 3 SOLVENT ATOMS : 296
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 32.17
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.81
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.237
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.186
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.210
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.180
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL
REMARK 3 BOND ANGLES : NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL
REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL
REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : NULL
REMARK 3 BOND ANGLES (DEGREES) : NULL
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL
REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: { A|9 - A|356 }
REMARK 3 ORIGIN FOR THE GROUP (A): -6.2518 -3.5743 20.3778
REMARK 3 T TENSOR
REMARK 3 T11: -0.0477 T22: -0.0577
REMARK 3 T33: -0.0487 T12: 0.0144
REMARK 3 T13: 0.0374 T23: 0.0187
REMARK 3 L TENSOR
REMARK 3 L11: 0.6941 L22: 0.3711
REMARK 3 L33: 1.4790 L12: 0.1707
REMARK 3 L13: 0.2083 L23: 0.1044
REMARK 3 S TENSOR
REMARK 3 S11: -0.0033 S12: 0.1017 S13: 0.0555
REMARK 3 S21: 0.0896 S22: -0.0507 S23: 0.0645
REMARK 3 S31: 0.1662 S32: 0.0827 S33: 0.0540
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5BUI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JUN-15.
REMARK 100 THE DEPOSITION ID IS D_1000210551.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 07-SEP-11
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ALS
REMARK 200 BEAMLINE : 5.0.2
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200 DATA SCALING SOFTWARE : SCALA
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21369
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.120
REMARK 200 RESOLUTION RANGE LOW (A) : 45.910
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3
REMARK 200 DATA REDUNDANCY : 4.300
REMARK 200 R MERGE (I) : 0.06800
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.12
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23
REMARK 200 COMPLETENESS FOR SHELL (%) : 95.1
REMARK 200 DATA REDUNDANCY IN SHELL : 3.90
REMARK 200 R MERGE FOR SHELL (I) : 0.37200
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.500
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 2OJG
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 45.58
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: RESERVOIR SOLUTION : 200MM CALCIUM
REMARK 280 ACETATE; 20% PEG3350 PROTEIN SOLUTION : 20.7MG/ML IN 20MM TRIS
REMARK 280 PH 7.5, 150MM NACL,1MM TCEP(NO GLYCEROL) FORMATION METHOD : CO-
REMARK 280 CRYSTALLIZATION PROTOCOL : COMPOUND (NVP-LLG040) WAS INCUBATED
REMARK 280 WITH THE PROTEIN AT 1MM FINAL CONCENTRATION BEFORE SETUP. EQUAL
REMARK 280 VOLUMES OF PROTEIN AND CRYSTALLANT WERE ADDED TO COVERSLIP
REMARK 280 METHOD: VAPOR DIFFUSION - HANGING DROP TEMPERATURE: 291.0 CRYO
REMARK 280 PROTOCOL: MOTHER LIQUOR (200MM CALCIUM ACETATE; 20% PEG3350) +
REMARK 280 20% GLYCEROL, VAPOR DIFFUSION, HANGING DROP
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.91500
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.03000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.62500
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.03000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.91500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.62500
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 110 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 16240 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A -2
REMARK 465 PRO A -1
REMARK 465 ALA A 0
REMARK 465 ALA A 1
REMARK 465 ALA A 2
REMARK 465 ALA A 3
REMARK 465 ALA A 4
REMARK 465 ALA A 5
REMARK 465 GLY A 6
REMARK 465 ALA A 7
REMARK 465 GLY A 8
REMARK 465 HIS A 178
REMARK 465 THR A 179
REMARK 465 GLY A 180
REMARK 465 PHE A 181
REMARK 465 LEU A 182
REMARK 465 THR A 183
REMARK 465 GLU A 184
REMARK 465 TYR A 185
REMARK 465 VAL A 186
REMARK 465 ALA A 187
REMARK 465 ARG A 357
REMARK 465 SER A 358
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 GLU A 10 CG CD OE1 OE2
REMARK 470 ARG A 77 CG CD NE CZ NH1 NH2
REMARK 470 LYS A 229 CD CE NZ
REMARK 470 ASN A 251 CG OD1 ND2
REMARK 470 LYS A 328 CG CD CE NZ
REMARK 470 ASP A 330 CG OD1 OD2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ARG A 146 -7.59 75.84
REMARK 500 ASP A 147 39.57 -141.67
REMARK 500 ASP A 165 80.02 65.05
REMARK 500 ASP A 173 88.35 -153.35
REMARK 500 LEU A 198 -59.71 -120.80
REMARK 500 LEU A 292 56.64 -96.50
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH A 796 DISTANCE = 6.06 ANGSTROMS
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 NI A 401 NI
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 HIS A 123 NE2
REMARK 620 2 CYS A 159 SG 106.2
REMARK 620 3 HIS A 176 ND1 65.0 54.1
REMARK 620 N 1 2
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue NI A 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 4V9 A 402
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 5BUE RELATED DB: PDB
REMARK 900 5BUE CONTAINS THE SAME PROTEIN WITH A DIFFERENT LIGAND
REMARK 900 RELATED ID: 5BUJ RELATED DB: PDB
REMARK 900 5BUJ CONTAINS THE SAME PROTEIN WITH A DIFFERENT LIGAND
DBREF 5BUI A 0 358 UNP P28482 MK01_HUMAN 2 360
SEQADV 5BUI GLY A -2 UNP P28482 EXPRESSION TAG
SEQADV 5BUI PRO A -1 UNP P28482 EXPRESSION TAG
SEQRES 1 A 361 GLY PRO ALA ALA ALA ALA ALA ALA GLY ALA GLY PRO GLU
SEQRES 2 A 361 MET VAL ARG GLY GLN VAL PHE ASP VAL GLY PRO ARG TYR
SEQRES 3 A 361 THR ASN LEU SER TYR ILE GLY GLU GLY ALA TYR GLY MET
SEQRES 4 A 361 VAL CYS SER ALA TYR ASP ASN VAL ASN LYS VAL ARG VAL
SEQRES 5 A 361 ALA ILE LYS LYS ILE SER PRO PHE GLU HIS GLN THR TYR
SEQRES 6 A 361 CYS GLN ARG THR LEU ARG GLU ILE LYS ILE LEU LEU ARG
SEQRES 7 A 361 PHE ARG HIS GLU ASN ILE ILE GLY ILE ASN ASP ILE ILE
SEQRES 8 A 361 ARG ALA PRO THR ILE GLU GLN MET LYS ASP VAL TYR ILE
SEQRES 9 A 361 VAL GLN ASP LEU MET GLU THR ASP LEU TYR LYS LEU LEU
SEQRES 10 A 361 LYS THR GLN HIS LEU SER ASN ASP HIS ILE CYS TYR PHE
SEQRES 11 A 361 LEU TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER
SEQRES 12 A 361 ALA ASN VAL LEU HIS ARG ASP LEU LYS PRO SER ASN LEU
SEQRES 13 A 361 LEU LEU ASN THR THR CYS ASP LEU LYS ILE CYS ASP PHE
SEQRES 14 A 361 GLY LEU ALA ARG VAL ALA ASP PRO ASP HIS ASP HIS THR
SEQRES 15 A 361 GLY PHE LEU THR GLU TYR VAL ALA THR ARG TRP TYR ARG
SEQRES 16 A 361 ALA PRO GLU ILE MET LEU ASN SER LYS GLY TYR THR LYS
SEQRES 17 A 361 SER ILE ASP ILE TRP SER VAL GLY CYS ILE LEU ALA GLU
SEQRES 18 A 361 MET LEU SER ASN ARG PRO ILE PHE PRO GLY LYS HIS TYR
SEQRES 19 A 361 LEU ASP GLN LEU ASN HIS ILE LEU GLY ILE LEU GLY SER
SEQRES 20 A 361 PRO SER GLN GLU ASP LEU ASN CYS ILE ILE ASN LEU LYS
SEQRES 21 A 361 ALA ARG ASN TYR LEU LEU SER LEU PRO HIS LYS ASN LYS
SEQRES 22 A 361 VAL PRO TRP ASN ARG LEU PHE PRO ASN ALA ASP SER LYS
SEQRES 23 A 361 ALA LEU ASP LEU LEU ASP LYS MET LEU THR PHE ASN PRO
SEQRES 24 A 361 HIS LYS ARG ILE GLU VAL GLU GLN ALA LEU ALA HIS PRO
SEQRES 25 A 361 TYR LEU GLU GLN TYR TYR ASP PRO SER ASP GLU PRO ILE
SEQRES 26 A 361 ALA GLU ALA PRO PHE LYS PHE ASP MET GLU LEU ASP ASP
SEQRES 27 A 361 LEU PRO LYS GLU LYS LEU LYS GLU LEU ILE PHE GLU GLU
SEQRES 28 A 361 THR ALA ARG PHE GLN PRO GLY TYR ARG SER
HET NI A 401 1
HET 4V9 A 402 22
HETNAM NI NICKEL (II) ION
HETNAM 4V9 3-(4-FLUOROPHENYL)-5-(PYRIDIN-2-YL)-4,5,6,7-TETRAHYDRO-
HETNAM 2 4V9 2H-PYRAZOLO[4,3-C]PYRIDINE
FORMUL 2 NI NI 2+
FORMUL 3 4V9 C17 H15 F N4
FORMUL 4 HOH *296(H2 O)
HELIX 1 AA1 HIS A 59 PHE A 76 1 18
HELIX 2 AA2 LEU A 110 GLN A 117 1 8
HELIX 3 AA3 SER A 120 ALA A 141 1 22
HELIX 4 AA4 LYS A 149 SER A 151 5 3
HELIX 5 AA5 ALA A 193 LEU A 198 1 6
HELIX 6 AA6 LYS A 205 ASN A 222 1 18
HELIX 7 AA7 HIS A 230 GLY A 243 1 14
HELIX 8 AA8 SER A 246 ASN A 251 1 6
HELIX 9 AA9 ASN A 255 LEU A 265 1 11
HELIX 10 AB1 PRO A 272 PHE A 277 1 6
HELIX 11 AB2 ASP A 281 LEU A 292 1 12
HELIX 12 AB3 ASN A 295 ARG A 299 5 5
HELIX 13 AB4 GLU A 301 ALA A 307 1 7
HELIX 14 AB5 HIS A 308 GLU A 312 5 5
HELIX 15 AB6 ASP A 316 GLU A 320 5 5
HELIX 16 AB7 GLU A 332 LEU A 336 5 5
HELIX 17 AB8 PRO A 337 THR A 349 1 13
HELIX 18 AB9 ALA A 350 GLN A 353 5 4
SHEET 1 AA1 2 GLU A 10 VAL A 12 0
SHEET 2 AA1 2 GLN A 15 PHE A 17 -1 O GLN A 15 N VAL A 12
SHEET 1 AA2 5 TYR A 23 GLY A 32 0
SHEET 2 AA2 5 GLY A 35 ASP A 42 -1 O TYR A 41 N THR A 24
SHEET 3 AA2 5 VAL A 47 ILE A 54 -1 O ILE A 51 N CYS A 38
SHEET 4 AA2 5 VAL A 99 ASP A 104 -1 O GLN A 103 N ALA A 50
SHEET 5 AA2 5 ASP A 86 ILE A 88 -1 N ILE A 88 O TYR A 100
SHEET 1 AA3 3 THR A 108 ASP A 109 0
SHEET 2 AA3 3 LEU A 153 LEU A 155 -1 O LEU A 155 N THR A 108
SHEET 3 AA3 3 LEU A 161 ILE A 163 -1 O LYS A 162 N LEU A 154
SHEET 1 AA4 2 VAL A 143 LEU A 144 0
SHEET 2 AA4 2 ARG A 170 VAL A 171 -1 O ARG A 170 N LEU A 144
LINK NE2 HIS A 123 NI NI A 401 1555 1455 1.94
LINK SG CYS A 159 NI NI A 401 1555 1455 2.30
LINK ND1 HIS A 176 NI NI A 401 1555 1555 2.35
CISPEP 1 GLY A 20 PRO A 21 0 5.14
SITE 1 AC1 4 HIS A 123 CYS A 159 HIS A 176 HOH A 678
SITE 1 AC2 12 TYR A 34 ALA A 50 GLN A 103 ASP A 104
SITE 2 AC2 12 MET A 106 GLU A 107 THR A 108 ASP A 109
SITE 3 AC2 12 LYS A 112 LEU A 154 ASP A 165 HOH A 528
CRYST1 43.830 71.250 120.060 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.022815 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014035 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008329 0.00000